PCT:祖细胞治疗
“祖细胞治疗”(Progenitor Cell Therapy)在医学领域常被简称为PCT,以方便日常书写和交流。该术语广泛用于描述利用祖细胞进行疾病干预和治疗的相关技术,是再生医学和细胞疗法中的重要研究方向。
Progenitor Cell Therapy具体释义
Progenitor Cell Therapy的英文发音
例句
- Conclusion HGF gene-modified fetal liver progenitor cell therapy could be a potential therapeutic approach in treatment of liver fibrosis.
- 结论HGF修饰的胎肝干细胞治疗可能成为肝纤维化潜在的治疗手段。
- Nevertheless, the list of promising cytokines continues to grow, and combinations of cytokines, with or without concurrent progenitor cell therapy, warrant further investigation.
- 尽管如此,有希望的细胞因子的目录仍在增加,无论是否合并祖细胞治疗(PCT),细胞因子的组合需要更多的研究。
- Rationale : Myocardial infarction ( MI ) rapidly depletes the endogenous cardiac progenitor-cell pool, and the inefficient recruitment of exogenously administered progenitor cells limits the effectiveness of cardiac cell therapy.
- 目的:心肌缺血导致内源性心肌祖细胞池迅速耗竭,通过注射外源性祖细胞的细胞治疗方法因为外源性心肌祖细胞不能有效地被招募到缺血部位而受到限制。
- Current clinical treatment is given to conventional cytokine therapy, but radiation survival of hematopoietic stem / progenitor cell proliferation and cytokine response capacity decreased significantly, and sustained cytokine combination therapy can cause side effects such as inflammation and immune responses.
- 目前临床上给予的常规治疗是细胞因子治疗,但是辐射后残存的造血干/祖细胞对细胞因子的增殖反应能力显著下降,而持续细胞因子联合治疗会引起炎症和免疫反应等副作用。
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若PCT词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。